Back to Search Start Over

Refractory Multiple Myeloma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

Source :
M2 Presswire. October 28, 2024
Publication Year :
2024

Abstract

M2 PRESSWIRE-October 28, 2024-: Refractory Multiple Myeloma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers (C)1994-2024 M2 COMMUNICATIONS RDATE:28102024 DelveInsight's, 'Refractory Multiple Myeloma Pipeline Insight 2024' report [...]

Subjects

Subjects :
Novartis Pharma AG -- Reports
Business -- Research
Multiple myeloma -- Reports
Carfilzomib -- Reports
Pharmaceutical industry -- Reports
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Presswire
Publication Type :
News
Accession number :
edsgcl.813872311

Tools

Authors Abstract Subjects Details